期刊文献+

IL-6、CD14、CD64检测在感染所致肝衰竭患者中意义 被引量:3

Effect of detection of IL6,CD14 and CD64 in patients with infection-induced liver failure
原文传递
导出
摘要 目的:探究CD14、CD64、IL-6在感染所致肝衰竭中的变化和诊断价值。方法:选取2016年7月~2017年7月在我院住院治疗的30例感染所致肝衰竭患者作为感染组,选取同时期在我院接受治疗的30例肝衰竭患者作为未感染组,选取同时期在我院接受健康监测的体检者10例作为对照组。对于确诊的腹水感染肝衰竭患者进行药物治疗;采集患者腹水和空腹外周静脉血,利用美国BD公司生产的FACSCalibur流式细胞仪测定患者的CD14、CD64水平;采用电化学发光免疫法(ELISA法)检测血清中IL-6。结果:感染组(治疗前)患者血液中CD14、CD64、IL-6含量明显高于未感染组和对照组,差异具有统计学意义(P <0. 05);感染组(治疗前)患者腹水中CD14、CD64、IL-6含量明显高于未感染组,差异具有统计学意义(P <0. 05)。治疗前感染组患者外周血中CD14、CD64、IL-6含量均低于腹水中CD14、CD64、IL-6含量,组间数据差异具有统计学意义(P <0. 05)。结论:CD14、CD64、IL-6在感染所致肝衰竭的诊断中具有一定的参考价值,同时腹水检查的敏感性优于血清检查。 Objective: To explore the changes and diagnostic value of CD14,CD64,and IL-6 in secondary liver failure. Method: 30 patients with secondary liver infection who were hospitalized in our hospital from July 2016 to July 2017 were selected as the infection group. 30 patients with hepatic failure treated in our hospital during the same period were selected as uninfected groups. 10 cases of physical examinations in our hospital during the same period for health monitoring were selected as the control group. Patients with confirmed liver failure secondary to ascites infection were treated with drugs;ascites and fasting peripheral venous blood were collected. The levels of CD14 and CD64 in patients were measured using a FACSCalibur flow cytometer produced by BD,USA;IL-6 in serum was measured by an electrochemiluminescence immunoassay( ELISA). Results: The levels of CD14,CD64,and IL-6 in the blood of infected patients( before treatment) were( 46. 32 ± 8. 41) mg · L-1,( 12 942. 21 ±328. 18) mol/cell,( 2 148. 13 ± 894. 35) pg·dl-1,significantly higher than those of the uninfected group( 0. 62 ±0. 20) mg·L-1,( 1 028. 45 ± 139. 41) mol/cell,( 84. 42 ± 56. 26) pg·dl-1,and the control group( 0. 52 ±0. 11) mg·L-1,( 983. 95 ± 126. 27) mol/cell,( 13. 52 ± 12. 71) pg·dl-1,The levels of CD14,CD64,and IL-6 in the ascitic fluid of the infected group( before treatment) were( 61. 24 ± 6. 41) mg·L-1,( 14 815. 06 ± 362. 21)mol/cell,and( 9 720. 82 ± 7 910. 25) pg·dl-1,respectively. In the uninfected group( 1. 92 ± 1. 20) mg·L-1,( 836. 13 ± 103. 22) mol/cell,( 1 648. 31 ± 1 321. 45) pg·dl-1,the difference was statistically significant( P <0. 05). The levels of CD14,CD64,and IL-6 in the peripheral blood of the infected patients were( 46. 32 ± 8. 41)mg·L-1,( 12 942. 21 ± 328. 18) mol/cell,and( 2 148. 13 ± 894. 35) pg·dl-1,respectively. Lowere than those in the ascites,CD14,CD64,IL-6 content( 61. 24 ± 6. 41) mg·L-1,( 14 815. 06 ±362. 21) mol/cell,( 9 720. 82 ±7 910. 25) pg/dl,the difference between the data was statistically significant( P < 0. 05). Conclusion: CD 14,CD64 and IL-6 have some reference value in the diagnosis of liver failure caused by infection,and the sensitivity of ascites examination is better than that of serum.
作者 张国民 韩智炜 牛兴杰 刘志慧 王鑫 ZHANG Guo-min;HAN Zhi-wei;NIU Xing-jie;LIU Zhi-hui;WANG Xin(Department of Infectious Diseases,Affiliated Hospital of ChengdeMedical College,Chengde 067000,China;Department of Gastroenterology,Affiliated Hospital of Chengde Medical College,Chengde 067000,China)
出处 《现代医学》 2019年第2期137-140,共4页 Modern Medical Journal
基金 承德市科技支撑计划项目(201701A077)
关键词 CD14 CD64 IL-6 感染所致肝衰竭 CD14 CD64 IL-6 infection-induced liver failure
  • 相关文献

参考文献12

二级参考文献136

  • 1张强,孙凤霞.79例亚急性肝衰竭患者的临床分析[J].临床肝胆病杂志,2012,28(1):53-54. 被引量:10
  • 2徐虹,王鲁文,王立坤,李汛,龚作炯.血清降钙素原检测对慢性重型乙型肝炎并发细菌感染的早期诊断价值[J].中华临床感染病杂志,2013,6(1):43-45. 被引量:7
  • 3中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:385
  • 4朱世殊,张鸿飞,陈菊梅,杨晓晋,徐志强,陈大为,董漪,徐长江.儿童肝衰竭临床特征的研究[J].中华实验和临床病毒学杂志,2004,18(4):366-369. 被引量:11
  • 5Renate G,Vauder M,Dave S,et al. Functionallmpairment of Myeloid and Plasmacytoid Dendritic Cells of Patients With Chronic Hepa-titis B[J]. Hepatology, 2004,40 : 738-746.
  • 6Hartemink KJ,Paul MA,SpijkstraJJ,etal. lmmunoparalysis as acause for invasive aspergillosis[J]. Intensive Care Med, 2003,29 : 2068-2071.
  • 7CAO J, BI S, MENG Q, et al. Genotyping of acute hepatitis A virus isolates from China, 2003-2008[J]. Journal of Medical Vi-rology, 2011, 83(7): 1134-1141.
  • 8KUMAR KJ, KUMAR HCK, MANJUNATH VG, et al. Hepatitis A in children-clinical course, complications and laboratory profile [J]. The Indian Journal of Pediatrics, 2014, 81(1): 15-19.
  • 9REMOVILLE N, ORIGER A, COUFFIGNAL S, et al. A hepatitis A, B, C and HIV prevalence and risk factor study in ever in- jecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations[J]. BMC Public Health, 2011, 11(1): 351-357.
  • 10PHAN C, HOLLINGER FB. Hepatitis A: Natural history, im- munopathogenesis, and outcome[J]. Clinical Liver Disease, 2013, 2(6): 231-234.

共引文献127

同被引文献49

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部